Rabien A - Search Results

1

Decreased Mitochondrial DNA Content Drives OXPHOS Dysregulation in Chromophobe Renal Cell Carcinoma.

Xiao Y, Clima R, Busch J, Rabien A, Kilic E, Villegas SL, Timmermann B, Attimonelli M, Jung K, Meierhofer D. Xiao Y, et al. Among authors: rabien a. Cancer Res. 2020 Sep 15;80(18):3830-3840. doi: 10.1158/0008-5472.CAN-20-0754. Epub 2020 Jul 21. Cancer Res. 2020. PMID: 32694149

2

Gene expression studies in prostate cancer tissue: which reference gene should be selected for normalization?

Ohl F, Jung M, Xu C, Stephan C, Rabien A, Burkhardt M, Nitsche A, Kristiansen G, Loening SA, Radonić A, Jung K. Ohl F, et al. Among authors: rabien a. J Mol Med (Berl). 2005 Dec;83(12):1014-24. doi: 10.1007/s00109-005-0703-z. Epub 2005 Oct 7. J Mol Med (Berl). 2005. PMID: 16211407

3

Decreased RECK expression indicating proteolytic imbalance in prostate cancer is associated with higher tumor aggressiveness and risk of prostate-specific antigen relapse after radical prostatectomy.

Rabien A, Burkhardt M, Jung M, Fritzsche F, Ringsdorf M, Schicktanz H, Loening SA, Kristiansen G, Jung K. Rabien A, et al. Eur Urol. 2007 May;51(5):1259-66. doi: 10.1016/j.eururo.2006.05.050. Epub 2006 Jun 14. Eur Urol. 2007. PMID: 16806661

4

ADAM8 expression in prostate cancer is associated with parameters of unfavorable prognosis.

Fritzsche FR, Jung M, Xu C, Rabien A, Schicktanz H, Stephan C, Dietel M, Jung K, Kristiansen G. Fritzsche FR, et al. Among authors: rabien a. Virchows Arch. 2006 Dec;449(6):628-36. doi: 10.1007/s00428-006-0315-1. Epub 2006 Nov 8. Virchows Arch. 2006. PMID: 17106710

5

[Human kallikreins as tumor markers. Validation of potential marker of prostate cancer in serum and tissue].

Rabien A, Kristiansen G, Diamandis EP, Jung K, Stephan C. Rabien A, et al. Urologe A. 2007 Sep;46(9):1070-1. doi: 10.1007/s00120-007-1420-8. Urologe A. 2007. PMID: 17605120 German. No abstract available.

6

[Tumor suppressor RECK in prostate carcinoma. Decreased RECK expression as indicator of proteolytic imbalance].

Rabien A, Jung M, Fritzsche F, Loening SA, Kristiansen G, Jung K. Rabien A, et al. Urologe A. 2007 Sep;46(9):1081-2. doi: 10.1007/s00120-007-1434-2. Urologe A. 2007. PMID: 17628776 German. No abstract available.

7

ADAM9 expression is a significant and independent prognostic marker of PSA relapse in prostate cancer.

Fritzsche FR, Jung M, Tölle A, Wild P, Hartmann A, Wassermann K, Rabien A, Lein M, Dietel M, Pilarsky C, Calvano D, Grützmann R, Jung K, Kristiansen G. Fritzsche FR, et al. Among authors: rabien a. Eur Urol. 2008 Nov;54(5):1097-106. doi: 10.1016/j.eururo.2007.11.034. Epub 2007 Nov 26. Eur Urol. 2008. PMID: 18061337

8

High expression of KLK14 in prostatic adenocarcinoma is associated with elevated risk of prostate-specific antigen relapse.

Rabien A, Fritzsche F, Jung M, Diamandis EP, Loening SA, Dietel M, Jung K, Stephan C, Kristiansen G. Rabien A, et al. Tumour Biol. 2008;29(1):1-8. doi: 10.1159/000132565. Epub 2008 May 23. Tumour Biol. 2008. PMID: 18497543

9

CD146 protein in prostate cancer: revisited with two different antibodies.

Fritzsche FR, Wassermann K, Rabien A, Schicktanz H, Dankof A, Loening SA, Dietel M, Jung K, Kristiansen G. Fritzsche FR, et al. Among authors: rabien a. Pathology. 2008 Aug;40(5):457-64. doi: 10.1080/00313020802197996. Pathology. 2008. PMID: 18604730

10

KLK15 is a prognostic marker for progression-free survival in patients with radical prostatectomy.

Rabien A, Fritzsche FR, Jung M, Tölle A, Diamandis EP, Miller K, Jung K, Kristiansen G, Stephan C. Rabien A, et al. Int J Cancer. 2010 Nov 15;127(10):2386-94. doi: 10.1002/ijc.25435. Int J Cancer. 2010. PMID: 20473923

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

50 results

Search Page

Filters